Latest News

5th Nov 2009 - AIMSPRO receives US orphan-drug designation for ALS

The US Government, through the Department of Health and Human Services, has designated AIMSPRO as an...

29th Sep 2009 - Ceremben Permit Approved

Daval Australia Limited has announced that the Australian Pesticides and Veterinary Medicines Author...

22nd Jul 2009 - Patent granted by the OAPI

A patent for ’The Treatment of HIV’ has been added to the AIMSPRO IP portfolio, having an effect...

2nd Jun 2009 - Health Director Article: Krabbe’s disease and Orphan Status

How does a small British Pharmaceutical company become focussed on Krabbe’s Leukodystrophy?... [ur...

2nd Jun 2009 - Health Director Article: Harmonisation Helps

As a small UK-based pharmaceutical company developing a single (currently unlicensed) biological pro...

    5th Nov 2009
AIMSPRO receives US orphan-drug designation for ALS
    29th Sep 2009
Ceremben Permit Approved
    22nd Jul 2009
Patent granted by the OAPI
Design by